BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 25853369)

  • 41. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
    Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.
    Langer P; Kann PH; Fendrich V; Habbe N; Schneider M; Sina M; Slater EP; Heverhagen JT; Gress TM; Rothmund M; Bartsch DK
    Gut; 2009 Oct; 58(10):1410-8. PubMed ID: 19470496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas.
    Ohtsuka T; Kono H; Tanabe R; Nagayoshi Y; Mori Y; Sadakari Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
    Am J Surg; 2012 Jul; 204(1):44-8. PubMed ID: 21996346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
    Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
    Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas.
    Sauvanet A; Gaujoux S; Blanc B; Couvelard A; Dokmak S; Vullierme MP; Ruszniewski P; Belghiti J; Lévy P
    Ann Surg; 2014 Aug; 260(2):364-71. PubMed ID: 24646561
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advantage of pancreaticogastrostomy in detecting recurrent intraductal papillary mucinous carcinoma in the remnant pancreas: a case of successful re-resection after pancreaticoduodenectomy.
    Tomimaru Y; Ishikawa O; Ohigashi H; Eguchi H; Yamada T; Sasaki Y; Miyashiro I; Ohue M; Yano M; Uehara H; Nakaizumi A; Imaoka S
    J Surg Oncol; 2006 May; 93(6):511-5. PubMed ID: 16615155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Natural history of branch-duct intraductal papillary mucinous neoplasms of the pancreas: a case report.
    Casadei R; Ricci C; D'Ambra M; Taffurelli G; Zingaretti CC; Pacilio CA; Calculli L; Pagano N; Minni F
    JOP; 2014 Jul; 15(4):391-3. PubMed ID: 25076351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Strategy in intraductal papillary mucinous neoplasm of the pancreas].
    Navarro Colás S; Vaquero Raya EC
    Gastroenterol Hepatol; 2012 Nov; 35(9):652-9. PubMed ID: 22832084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up.
    Xourafas D; Tavakkoli A; Clancy TE; Ashley SW
    Surgery; 2015 Mar; 157(3):473-83. PubMed ID: 25596773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
    Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
    World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention.
    Hart SL; Torbit LA; Crangle CJ; Esplen MJ; Holter S; Semotiuk K; Borgida A; Ardiles P; Rothenmund H; Gallinger S
    Psychooncology; 2012 Dec; 21(12):1324-30. PubMed ID: 21774034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pancreatic cancer screening: identifying premalignant disease.
    James TA; Gibbs JF
    Future Oncol; 2005 Apr; 1(2):191-5. PubMed ID: 16555989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
    Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
    Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?
    Roch AM; Kim RC; Nguyen TK; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
    J Surg Oncol; 2023 Aug; 128(2):289-294. PubMed ID: 37083062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidental findings in pancreas screening programs for high-risk individuals: Results from three European expert centers.
    Ibrahim IS; Brückner C; Carrato A; Earl J; Inderson A; de Vos Tot Nederveen Cappel WH; Mintziras I; Matthäi E; Figiel J; Wasser M; Moreau H; Bonsing B; Slater EP; Bartsch DK; Vasen HF
    United European Gastroenterol J; 2019 Jun; 7(5):682-688. PubMed ID: 31210946
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.
    Konings IC; Harinck F; Poley JW; Aalfs CM; van Rens A; Krak NC; Wagner A; Nio CY; Sijmons RH; van Dullemen HM; Vleggaar FP; Ausems MG; Fockens P; van Hooft JE; Bruno MJ;
    Pancreas; 2017 Jan; 46(1):28-34. PubMed ID: 27846136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of genetic risk for pancreatic adenocarcinoma.
    Flores K; Dinh K; Rouleau E; Whalen G; Wassef W; LaFemina J
    Cancer Genet; 2015 Nov; 208(11):559-63. PubMed ID: 26481832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging?
    Vullierme MP; Lagadec M
    Diagn Interv Imaging; 2016 Dec; 97(12):1233-1240. PubMed ID: 27816353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.